First Time Loading...

Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Watchlist
Price: 28.47 NZD 1.71% Market Closed
Updated: Apr 30, 2024
Section:
 

Relative Value

The Relative Value of one FPH stock under the Base Case scenario is 27.31 NZD. Compared to the current market price of 28.47 NZD, Fisher & Paykel Healthcare Corporation Ltd is Overvalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FPH Relative Value
Base Case
27.31 NZD
Overvaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.8
P/S
P/S
Price to Sales
9.8
vs History
33
vs Industry
14
Median 3Y
8.8
Median 5Y
9
Industry
2.4
Forward
9.4
More Details
63.2
P/E
P/E
Price to Earnings
63.2
vs History
6
vs Industry
7
Median 3Y
42.3
Median 5Y
46.9
Industry
23.2
Forward
62.6
More Details
42.1
P/OCF
P/OCF
Price to OCF
42.1
vs History
44
vs Industry
8
Median 3Y
36.2
Median 5Y
38.3
Industry
15.5
More Details
101.2
P/FCFE
P/FCFE
Price to FCFE
101.2
vs History
34
vs Industry
5
Median 3Y
84.4
Median 5Y
84.4
Industry
23.5
More Details
9.4
P/B
P/B
Price to Book Value
9.4
vs History
58
vs Industry
7
Median 3Y
8.8
Median 5Y
10
Industry
2.2
More Details
9.9
EV/S
EV/S
Enterprise Value to Sales
9.9
vs History
33
vs Industry
13
Median 3Y
8.8
Median 5Y
8.9
Industry
2.5
Forward
9.5
More Details
16.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
16.6
vs History
26
vs Industry
12
Median 3Y
14
Median 5Y
14.4
Industry
5.2
More Details
46.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
46.8
vs History
7
vs Industry
5
Median 3Y
32.3
Median 5Y
35.2
Industry
12.5
Forward
35.1
More Details
46.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
46.8
vs History
7
vs Industry
7
Median 3Y
32.3
Median 5Y
35.2
Industry
17.2
Forward
46.2
More Details
42.7
EV/OCF
EV/OCF
Enterprise Value to OCF
42.7
vs History
44
vs Industry
8
Median 3Y
36
Median 5Y
38.4
Industry
15.1
More Details
544.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
544.1
vs History
3
vs Industry
0
Median 3Y
71.2
Median 5Y
75.9
Industry
19.7
More Details
8
EV/IC
EV/IC
Enterprise Value to IC
8
vs History
66
vs Industry
11
Median 3Y
7.7
Median 5Y
9.3
Industry
2
More Details

Multiples Across Competitors

FPH Competitors Multiples
Fisher & Paykel Healthcare Corporation Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
16.5B NZD 9.8 63.2 46.8 46.8
US
Abbott Laboratories
NYSE:ABT
184.4B USD 4.6 32.7 19.3 28.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
131.7B USD 18 66.3 54.3 68.1
US
Stryker Corp
NYSE:SYK
128.4B USD 6.3 40.6 25.3 31.3
IE
Medtronic PLC
NYSE:MDT
107.2B USD 3.3 25.5 13.6 19.2
US
Boston Scientific Corp
NYSE:BSX
105.3B USD 7.4 67.1 31.2 46.6
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD 3.5 55.5 18.6 39.3
DE
Siemens Healthineers AG
XETRA:SHL
57.8B EUR 2.7 38.1 18.3 30.9
US
Edwards Lifesciences Corp
NYSE:EW
51.1B USD 8.5 36.4 26.3 28.5
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3
US
Dexcom Inc
NASDAQ:DXCM
49.5B USD 13.7 91.5 61.6 80.3

See Also

Summary
FPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
FPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FPH stock valuation using valuation multiples.
Wall Street Estimates
FPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.